Brown Brothers Harriman & Co’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5K Sell
252
-200
-44% -$20.7K ﹤0.01% 1242
2026
Q1
$43.7K Buy
452
+76
+20% +$7.79K ﹤0.01% 1065
2025
Q4
$39.9K Buy
376
+56
+18% +$6.49K ﹤0.01% 1076
2025
Q3
$40.6K Buy
320
+78
+32% +$9.29K ﹤0.01% 1038
2025
Q2
$29.7K Buy
+242
New +$27.6K ﹤0.01% 1028
2022
Q4
Sell
-225
Closed -$10K 1324
2022
Q3
$10K Buy
+225
New +$11.3K ﹤0.01% 1148
2021
Q1
Sell
-55
Closed -$4K 1140
2020
Q4
$4K Buy
55
+3
+6% +$176 ﹤0.01% 959
2020
Q3
$3K Buy
+52
New +$2.67K ﹤0.01% 871
2019
Q4
Sell
-15
Closed -$1K 1150
2019
Q3
$1K Hold
15
﹤0.01% 1114
2019
Q2
$1K Buy
+15
New +$728 ﹤0.01% 1005
2017
Q2
Sell
-145
Closed -$5K 772
2017
Q1
$5K Hold
145
﹤0.01% 716
2016
Q4
$5K Hold
145
﹤0.01% 758
2016
Q3
$5K Hold
145
﹤0.01% 679
2016
Q2
$4K Buy
+145
New +$4.54K ﹤0.01% 732

Other funds holding EHC

Brown Brothers Harriman & Co's EHC Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Encompass Health (EHC) stake by 44% in Q2 2026, selling an estimated $20.7K and leaving 252 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Brown Brothers Harriman & Co first reported a position in EHC in Q2 2016 and has held it in 14 quarters since. The position peaked at $43.7K in Q1 2026. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Brown Brothers Harriman & Co held 252 shares of Encompass Health worth $25.5K as of Q2 2026.
  • Brown Brothers Harriman & Co sold 200 Encompass Health shares in Q2 2026, an estimated $20.7K.
  • Encompass Health made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1242 holding.
  • Brown Brothers Harriman & Co first reported a position in Encompass Health in Q2 2016 and has held it in 14 quarters since.
  • Brown Brothers Harriman & Co's Encompass Health position peaked at $43.7K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.